Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 1, 2008, Pages 25-30

  Arpino, P A ^a   Kalafatas, K ^a   Thompson, B T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Agitation; Dexmedetomidine; Extubation; Intensive care unit

Indexed keywords

DEXMEDETOMIDINE; HALOPERIDOL; HYPERTENSIVE FACTOR; LORAZEPAM; MIDAZOLAM; OPIATE; PHENYLEPHRINE; PROPOFOL;

ADJUVANT THERAPY; ADULT; AGITATION; ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; EXTUBATION; FEMALE; HEART RATE; HUMAN; INTENSIVE CARE UNIT; MALE; MEAN ARTERIAL PRESSURE; SEDATION; SIDE EFFECT;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; ANALGESICS; BLOOD PRESSURE; DEXMEDETOMIDINE; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PSYCHOMOTOR AGITATION; TREATMENT OUTCOME; VENTILATOR WEANING;

EID: 38349065059     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00883.x     Document Type: Article

References (13)

1. Esteban A, Frutos F, Tobin MJ et al. (1995) A comparison of four methods of weaning patients from mechanical ventilation. New England Journal of Medicine, 332, 345 350.
2. Brochard L, Rauss A, Benito S et al. (1994) Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. American Journal of Respiratory and Critical Care Medicine, 150, 896 903.
3. Virtanen R, Savola JM, Saano V et al. (1988) Characterization of the selectivity, specificity and potency of medetomidine as an alpha2-adrenoceptor agonist. European Journal of Pharmacology, 150, 9 14.
4. Aantaa R, Kallio A, Virtanen R (1993) Dexmedetomidine, a novel alpha-2-adrenergic agonist. A review of its pharmacodynamic characteristics. Drugs of the Future, 18, 49 56.
5. Belleville JP, Ward DS, Bloor BC et al. (1992) Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology, 77, 1125 1133.
6. Venn RM, Hell J, Grounds RM (2000) Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Critical Care, 4, 302 308.
7. Scheinin H, Jaakola M-L, Sjövall S et al. (1993) Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology, 78, 1065 1075.
8. Venn RM, Bradshaw C, Spencer R et al. (1999) Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia, 54, 1136 1142.
9. Venn RM, Newman J, Grounds M (2003) A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Medicene, 29, 201 207.
10. Shehabi Y, Ruettimann U, Adamson H et al. (2004) Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Medicine, 30, 2188 2196.
11. Sessler C, Gosnell M, Grap MJ et al. (2002) The Richmond agitation-sedation scale. Validity and reliability in adult intensive care unit patients. American Journal of Respiratory and Critical Care Medicine, 166, 1338 1344.
12. Riker RR, Picard JT, Fraser GL (1999) Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Critical Care Medicine, 27, 1325 1329.
13. Siobal MS, Kallet RH, Kivett VA et al. (2006) Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: a pilot study. Respiratory Care, 51, 492 496.